CDC ADVISERS VOTE TO NOT RECOMMEND PFIZER/BIONTECH VACCINE BOOSTER FOR PEOPLE AGED 18-64 WHO WORK OR ARE IN INSTITUTIONS WHERE RISK OF INFECTION IS HIGH, BASED ON INDIVIDUAL BENEFIT/RISK
Stock market news
- Stock
- Stock market news
- Economy
- Cdc Advisers Vote To Not Recommend Pfizer/Biontech Vaccine Booster For People Aged 18-64 Who Work Or Are In Institutions Where Risk Of Infection Is High, Based On Individual Benefit/Risk